Please login to the form below

Not currently logged in
Email:
Password:

generics

This page shows the latest generics news and features for those working in and with pharma, biotech and healthcare.

Pfizer goes big on gene therapy with $500m facility spend

Pfizer goes big on gene therapy with $500m facility spend

Meanwhile, Pfizer has also been stripping out businesses it sees as lying outside its core focus of innovative medicines, selling off its older and generic drugs to Mylan earlier this year

Latest news

More from news
Approximately 79 fully matching, plus 1,743 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    Lilly’s authorised generic. One company, Eli Lilly, has responded to the pleas for more affordable insulins, and launched a half price ‘authorised generic’ version of Humalog in the US. ... Lilly's authorised generic product. However, Elizabeth

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Set up in May this year, largely by parents of children with cystic fibrosis, the Buyers’ Club aims to import generic versions of Orkambi from abroad and bypass Vertex’s European ... Meticulous preparations. The supply of the generic drug comes from

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    Whether we market branded products that offer no real superiority over generics, biosimilars or me-toos or we sell innovative products whose price differential is not financially justified, much of what

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    J&J needs the drug to hit the ground running because its existing prostate cancer blockbuster Zytiga is faceing generic competition in the US, which accounts for around half of the

  • Why precision medicine demands precision engagement Why precision medicine demands precision engagement

    Every interaction needs to be targeted specifically at the healthcare professional’s needs and interests in order to be valuable – generic information is no longer sufficient.

More from intelligence
Approximately 6 fully matching, plus 160 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 49 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics